Dyspeptic symptoms in patients with type 1 diabetes: endoscopic findings, helicobacter pylori infection, and associations with metabolic control, mood disorders and nutritional factors by Faria, Mariza et al.
UNIVERSIDADE ESTADUAL DE CAMPINAS
SISTEMA DE BIBLIOTECAS DA UNICAMP
REPOSITÓRIO DA PRODUÇÃO CIENTIFICA E INTELECTUAL DA UNICAMP
Versão do arquivo anexado / Version of attached file:
Versão do Editor / Published Version
Mais informações no site da editora / Further information on publisher's website:
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000200129
DOI: 10.1590/2359-3997000000025
Direitos autorais / Publisher's copyright statement:
©2015 by Sociedade Brasileira de Endocrinologia e Metabologia. All rights reserved.
DIRETORIA DE TRATAMENTO DA INFORMAÇÃO
Cidade Universitária Zeferino Vaz Barão Geraldo






















Arch Endocrinol Metab. 2015;59/2
Dyspeptic symptoms in patients 
with type 1 diabetes: endoscopic 
findings, Helicobacter pylori 
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ABSTRACT
Objectives: To evaluate, in a group of patients with long-standing type 1 diabetes (DM1), an associa-
tion of dyspepsia symptoms with: changes in the gastroduodenal mucosa, infection by Helicobacter 
pylori, glycemic control, and psychological and nutritional factors. Subjects and methods: A total of 
32 patient with DM1 were studied (age: 38 ± 9 years; females: 25; diabetes duration: 22 ± 5 years). All 
patients answered a standardized questionnaire for the evaluation of gastrointestinal symptoms and 
underwent upper gastrointestinal endoscopy, with gastric biopsies for the evaluation of Helicobacter 
pylori infection. The presence of anxiety and depression was evaluated by the HAD scale. Nutritional 
parameters were BMI, arm and waist circumference, skinfold measurement, and body fat percent-
age. Results: Upper endoscopy detected lesions in the gastric mucosa in 34.4% of the patients, with 
similar frequency in those with (n = 21) and without dyspepsia (n = 11). The patients with dyspepsia 
complaints showed greater frequency of depression (60% vs. 0%; p = 0.001), higher values for HbA1c 
(9.6 ± 1.7 vs. 8.2 ± 1.3%; p = 0.01) and lower values for BMI (24.3 ± 4.1 vs. 27.2 ± 2.6 kg/m2; p = 0.02), 
body fat percentage (26.6 ± 6.2 vs. 30.8 ± 7.7%; p = 0.04), and waist circumference (78.7 ± 8 vs. 85.8 ± 
8.1 cm; p = 0.02). No association was found between the symptoms and the presence of Helicobacter 
pylori. Conclusions: Dyspepsia symptoms in patients with long-standing DM1 were associated with 
glycemic control and depression, and they seem to negatively influence the nutritional status of these 
patients.  Arch Endocrinol Metab. 2015;59(2):129-36 
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R ecent studies indicate that the prevalence of gas-trointestinal symptoms in patients with type 1 
diabetes (DM1) is greater than that observed in the 
overall population (1-3). It was also demonstrated that 
this clinical picture has a negative impact in the quality 
of life of these patients (4). However, the mechanisms 
responsible for digestive manifestations in diabetes have 
not been elucidated, yet (5). 
Few authors have used upper digestive endoscopy 
(UDE) to analyze the presence of mucosal lesions that 
could explain the esophageal and dyspeptic complaints 
in diabetic patients. In one study, endoscopic evalu-
ation showed that the lesions in the esophagogastric 
mucosa were more frequent in diabetic patients (most 
of them with type 2 diabetes) than in non-diabetic con-
trols. However, no relationship was observed between 
the lesions found and the presence of digestive symp-
toms (6). On the other hand, some authors observed a 
similar frequency of endoscopic lesions in diabetic and 
non-diabetic control patients (7). 
Studies that investigated the relationship between 
digestive symptoms and Helicobacter pylori infection 
(8), glycemic control (1,9), and abnormal autonomic 
function (5) in diabetes also showed contradictory re-
sults. Besides, no direct relationship was demonstrated 
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Dyspepsia in diabetes type 1
The association between gastrointestinal symptoms 
and psychological factors, particularly anxiety and de-
pression, is growingly recognized in the literature since 
the studies which were carried out in patients with func-
tional diseases, such as functional dyspepsia and irritable 
bowel syndrome (12). There is evidence of increased 
prevalence of anxiety and depression in diabetic patients 
(13,14), but the relationship between these disorders 
and the presence of gastrointestinal symptoms have sel-
dom been investigated in diabetes. An Australian study 
that evaluated both type 1 and type 2 diabetes patients 
demonstrated that digestive symptoms were twice more 
frequent in those patients that showed anxiety and/or 
depression (15). This information indicates the need 
for new studies to confirm this relationship in patients 
with DM1. Besides, there are no studies involving the 
possible influence of dyspeptic symptoms in the nutri-
tional picture of patients with DM1. 
Therefore, the objectives of this study were to eva-
luate, in a group of patients with long-term DM1, the 
relationship between dyspeptic symptoms with the fol-
lowing factors: changes in the gastroduodenal mucosa; 
infection by Helicobacter pylori; glycemic control; and 
psychological and nutritional factors. 
SUBJECTS AND METHODS 
A total of 32 patients with DM1 were seen at the DM1 
outpatient clinic of the Endocrinology Division at the 
Hospital das Clínicas da Unicamp (HC-Unicamp). 
Mean age of the participants in the study was 38 ± 9 
years, with 25 (78.1%) female patients and 7 (21.9%) 
male ones. DM1 diagnosis was determined by the cri-
teria of the American Diabetes Association (ADA) (16). 
Inclusion criteria were: patients had to be older than 
18 years of age, diabetes diagnosis should have been 
established more than 10 years before, written consent 
for upper digestive endoscopy (UDE). Exclusion crite-
ria were: pregnancy, previous gastrointestinal tract sur-
gery, renal failure with dialysis, concurrent diseases that 
may cause changes in gastrointestinal motility. 
The control group for the presence of gastrointes-
tinal symptoms was made up by 50 healthy volunteers 
(30 women and 20 men, aged 33 ± 8 years) recruited 
among employees and students at the HC and Gastro-
centro-Unicamp. The control group was matched to the 
patient group based on age, sex and BMI. None of the 
volunteers had cardiac or gastrointestinal disease, arterial 
hypertension, diabetes or previous abdominal surgery. 
This study was approved by the Research Ethics 
Committee at Unicamp. All participants signed a writ-
ten informed consent term.
Clinical and laboratory assessment 
Factors related to DM1, including duration of the 
disea se, chronic complications (retinopathy, peripheral 
neuropathy, and diabetic nephropathy), and laboratory 
parameters, including fasting glucose, urea, creatinine, 
creatinine clearance, and TSH were obtained from pa-
tient records. Glycemic control was analyzed by means 
of glycated hemoglobin (HbA1c) obtained by high ef-
ficiency liquid chromatography. Levels above 7% were 
considered inadequate glycemic control.
Diabetic retinopathy was diagnosed by fundoscopy 
carried out by an ophthalmologist at HC-Unicamp. 
Diabetic nephropathy was evaluated by means of mi-
croalbuminuria in a morning urine sample; nephro-
pathy was considered when two values observed on 
two different days were above the normal value (up to 
30 mg/g creatinine), in the absence of urinary infec-
tion. The diagnosis of peripheral neuropathy was deter-
mined using a 10 g-monofilament for pain sensation, 
128 Hz tuning fork for vibration perception, assess-
ment of achilles and patellar reflexes, as well as palpa-
tion of dorsalis pedis and posterior tibial pulses. 
Gastrointestinal symptoms
Gastrointestinal symptoms were analyzed in patients 
and controls using a standardized questionnaire that 
was previously validated (17). The following esopha-
geal symptoms were analyzed: dysphagia, heartburn 
and regurgitation. Dyspeptic symptoms included pain 
or epigastric burning, postprandial bloating, nausea, 
and vomiting. Intestinal symptoms analyzed were: ab-
dominal distention, abdominal pain, constipation, diar-
rhea, and fecal incontinence. Each symptom received a 
score from 0 to 4, according to the intensity, as follows: 
0 = no symptom, 1 = mild (symptoms can be ignored), 
2 = moderate (symptoms cannot be ignored, but do 
not influence daily activities), 3 = severe (symptoms in-
fluence daily activities). Only moderate or severe symp-
toms that occurred more than once a week were con-
sidered in the analysis of the data. 
Upper digestive endoscopy 
Upper digestive endoscopy was carried out in order to 
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Dyspepsia in diabetes type 1
intestinal symptoms. Besides, gastric biopsy fragments 
were collected for H. pylori analysis (body and antrum) 
and fragments of the bulb and postbulbar portion (dis-
tal to the duodenal papilla) were collected to the analy-
sis of celiac disease. 
Analysis of H. pylori infection
Analysis of H. pylori was carried out by the urease test 
and histological examination of fragments collected in 
the endoscopy. Infection was considered to be negative 
when both tests were negative. 
Diagnosis of celiac disease 
Considering the increased prevalence of celiac disease in 
DM1 (18), and the possible nutritional changes caused 
by this comorbidity, the presence of celiac disease in 
the patient group was analyzed by means of histological 
examination of duodenal biopsies. 
Assessment of mood disturbances by the HAD scale 
The presence of anxiety and depression was evaluated 
using the Portuguese version of the HAD (Hospital 
Anxiety and Depression) scale, which was validated in 
Brazil (19). This scale is divided into subscales for anxi-
ety and depression, and values over 8 in each subscale 
indicate anxiety or depression. 
Assessment of nutritional status 
Nutritional status of the patients was assessed according 
to standardized protocols (20) that yielded the follow-
ing anthropometric indices: body mass index (BMI), 
calculated as weight (kg)/height2 (m); arm circumfer-
ence (AC); corrected arm muscle area (cAMA); waist cir-
cumference (WC); and skinfold measurements: tricipital 
(TSF), bicipital (BSF), subscapular (SSSF) and suprailiac 
(SISF). Body fat percentage was calculated based on these 
indices. Measurement of arm and waist circumferences 
were carried out with an inextensible tape, and skinfolds 
were measured with a Lange caliper (Cambridge Scien-
tific Industries Cambridge, MA) with 0.2 mm accuracy. 
Statistical analysis
Results were expressed as means ± SD. Statistical analy-
sis was carried out using the Mann-Whitney, Chi-Square 
and Fischer Exact Test, as necessary. The comparison 
between multiple variables was carried out by the analy-
sis of variance (ANOVA) and Tukey test. Correlation 
analysis was carried out using Spearman correlation co-
efficient. Statistical significance was set at p < 0.05. 
RESULTS
Clinical and demographic characteristics of the 
patients
Table 1 shows the main demographic and clinical 
characteristics of the 32 patients with DM1. Mean time 
from diagnosis was 22 ± 5 years.
All patients used insulin, and none of them was un-
der treatment with metformin. Peripheral neuropathy 
was found in 46.9% of the participants. Mean HbA1c 
was 9.1 ± 1.7%, indicating that the group of patients 
studied had inadequate glycemic control. Only one pa-
tient (3%) showed good control, with HbA1c < 7%. 
There were no significant differences (p > 0.05) be-
tween men and women in relation to the clinical pa-
rameters.  
Gastrointestinal symptoms
Table 2 shows the frequency of the different gastroin-
testinal symptoms reported by diabetic patients and the 
control group. Compared with the control group, dia-
betic patients presented significantly greater frequen-
cies of dysphagia, heartburn, regurgitation, postprandi-
al bloating, nausea, vomiting, and intestinal symptoms 
(constipation, diarrhea, abdominal distention, and fecal 
incontinence). 
Considering the group of symptoms, it was obser-
ved that 21 (65.6%) of the patients showed dyspepsia. 
The main dyspepsia complaint was postprandial fullness 
more than three times a week in all cases. In patients 
with dyspepsia, 7 (33.3%) presented symptoms asso-
ciated with gastroesophageal reflux (heartburn and/or 
regurgitation) and 18 (85.7%) showed associated intes-
tinal complaints, such as constipation, diarrhea, pain or 
abdominal distention. None of the patients presented 
with exclusively reflux symptoms, and none of them 
used gastric acid secretion inhibitors or prokinetic dru-
gs in the treatment of the symptoms. 
Nineteen (90.5%) of the patients with dyspepsia 
symptoms related the onset or worsening of the gas-
trointestinal symptoms with the ingestion of specific 
foods. The most common foods reported were: milk, 
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Table 2. Frequency of gastrointestinal symptoms in patients with DM1 
and in the control group
Symptoms DM1 patients(n = 32)
Controls
(n = 50) p
Dysphagia 6 (18.7%) 1 (2%) 0.01
Heartburn and/or 
regurgitation
7 (21.9%) 3 (6%) 0.04
Postprandial fullness 15 (46.9%) 5 (10%) 0.001
Epigastralgia 9 (28.1%) 11 (22%) 0.60
Nausea/vomiting 7 (21.9%) 3 (6%) 0.04
Abdominal distention 13 (40.6%) 8 (16%) 0.02
Constipation 9 (28.1%) 5 (10%) 0.04
Diarrhea 6 (18.7%) 0 (0%) 0.002
Abdominal pain 3 (9.4%) 1 (2%) 0.29
Fecal incontinence 5 (15.6%) 0 (0%) 0.01
Association between dyspeptic symptoms, glycemic 
control and diabetes complications 
Comparisons between diabetic patients with and with-
out dyspepsia are shown in tables 1 and 3-5. Table 1 
shows that diabetic patients with dyspepsia presented 
significantly higher levels of HbA1c when compared 
with diabetic patients without dyspepsia, indicating 
that this subgroup had worse glycemic control. 
There was no statistical association (p > 0.05) betwe-
en dyspepsia symptoms and diabetes complications (pe-
ripheral neuropathy, retinopathy, nephropathy), or with 
any of the other parameters analyzed: sex, age, fasting 
glucose, creatinine values, creatinine clearance, and TSH. 
Upper digestive endoscopy findings 
UDE analysis showed that most of the patients with 
DM1 (65.6%) did not present relevant changes in the 
mucosa of the digestive system. The most important 
findings were severe erosive gastritis in two patients 
and a healing gastric ulcer in a patient. The comparison 
of patients with and without dyspepsia did not show 
significant differences in the frequency of endoscopic 
lesions. 
Helicobacter pylori infection
H. pylori infection was found in eleven patients (34.4%). 
The urease test and histological examination were in agree-
ment in all cases. None of the patients reported previous 
treatment of the infection. There were no statistical dif-
ferences between dyspeptic and asymptomatic patients 
as for the presence of the bacteria (Table 3).
Presence of celiac disease
Histological examination of the duodenal biopsies con-
firmed the diagnosis of celiac disease in one patient. 
Presence of anxiety and depression 
Thirty patients completed the HAD scale. According 
with the scores, 19 patients (63.3%) presented some 
kind of mood alteration. Ten patients (33.3%) pre-
sented anxiety associated with depression, 7 (23.3%) 
showed only anxiety, and two (6.7%) presented only 
depression. 
There was no significant correlation (p > 0,05) be-
tween the scores for anxiety and depression, HbA1c 
values and any other biochemical parameter. No statis-
tically significant association was observed with gender, 
age, or diabetes complications, either. 
Table 4 shows that 60% of the dyspeptic patients 
and 50% of the diabetic patients without symptoms of 
Dyspepsia in diabetes type 1
Table 1. Demographic and clinical characteristics of patients with DM1. Comparison of patients with and without dyspepsia




 (n = 11) p











Time since diabetes diagnosis (years) 22 ± 5 25 ± 6 21 ± 5 0.06
Peripheral neuropathy n (%) 15 (46.9) 10 (47.6) 5 (45.4) 1
Retinopathy (%) 28 (87.5) 17 (81) 11 (100) 0.27
Diabetic nephropathy n (%) 22 (68.7) 16 (76.2) 6 (54.5) 0.25
Smoking n (%) 4 (12.5) 4 (19) 0 (0) 0.27
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dyspepsia presented anxiety (p > 0.05). On the other 
hand, depression was identified in 60% of the patients 
with dyspeptic complaints, whereas none of the dia-
betic without dyspepsia presented this disorder (p = 
0.001). In accordance with these data, the score in the 
depression subscale was significantly greater in patients 
with dyspeptic symptoms. 
Association between dyspeptic symptoms and 
nutritional parameters
Mean values of anthropometric parameters are presen-
ted in table 5. For the analysis of the results, the patient 
diagnosed with celiac disease was excluded, once she 
was malnourished. According to the BMI, 13 patients 
(43.3%) were overweight and one (3.3%) was obese. 
When compared with patients without dyspeptic 
complaints, patients with dyspepsia presented signi-
ficantly decreased values (p < 0.05) for the following 
parameters: BMI, waist circumference, and fat percen-
tage. 
There was no association between anthropometric 
data and any of the other clinical and laboratorial para-
meters analyzed. Besides, there was no statistical asso-
ciation between nutritional factors, anxiety and depres-
sion (p > 0.05).
DISCUSSION
Most of the studies that investigated gastrointestinal 
symptoms in DM1 were carried out in groups that were 
mostly made up by patients with DM2 (3). Besides, 
the analysis of different study groups shows wide vari-
ability in terms of clinical and laboratory characteristics 
and length of the disease in patients with DM1. The 
advantage of the present study was to analyze dyspep-
tic symptoms in a homogenous group of patients with 
Dyspepsia in diabetes type 1
Table 3. Lesions observed in upper digestive endoscopy and H. pylori infection in patients with type 1 diabetes and without dyspepsia




(n = 11) p
Erosive lesions/peptic ulcer
Mild erosive gastritis



















H. pylori infection 11 (34.4%) 6 (28.6%) 5 (45.4%) 0.44
Table 4. Anxiety and depression in patients with DM1 according to the HAD scale. Comparison between diabetic patients with and without dyspeptic 
symptoms 

























Table 5. Anthropometric data of diabetic patients according to the presence or absence of dyspeptic symptoms 




 (n = 11) p
BMI (kg/m2) 25.3 ± 3.8 24.3 ± 4.1 27.2 ± 2.6 0.02
Body fat (%) 28.3 ± 7.1 26.6 ± 6.2 30.8 ± 7.7 0.04
Waist circumference (cm) 81.5 ± 8.6 78.7 ± 8 85.8 ± 8.1 0.02
Arm circumference (cm) 29.7 ± 3.8 28.4 ± 3.8 31.5 ± 3 0.08
Tricipital skinfold (mm) 15.9 ± 5.7 14.6 ± 5.9 17.6 ± 5.2 0.14
Corrected arm muscle area  (cm2) 42.7 ± 12 39.1 ± 12.3 47.8 ± 10 0.06
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DM1 in relation to the length of the disease, the pres-
ence of diabetes complications, and even in terms of 
inadequate glycemic control.  
Patients were characterized by the high frequency 
of gastrointestinal symptoms, which was significantly 
greater than that in the control group, confirming the 
results of previous studies that demonstrated that di-
gestive symptoms are more frequent in diabetic patients 
compared with non-diabetic controls (1-3). However, 
it is important to observe that the prevalence of dyspep-
tic complaints observed in the present cases was higher 
than that reported in population studies, and cannot be 
generalized to the whole population of DM1 patients. 
This may be due to the fact that the study protocol 
required upper endoscopy to be carried out. Therefo-
re, it is possible that diabetic patients with dyspep-
tic complaints had more interest in taking part in 
the study, what may have increased the frequency of 
changes in the group studied. Similarly, the predo-
minance of female patients may also be related with 
greater interest in taking part in the study, once pre-
vious observations demonstrated that gastrointesti-
nal symptoms are more frequent in women than in 
men with DM1 (2). Considering this possible bias, all 
statistical analyses considered a possible gender effect. 
Upper endoscopy showed that a large number of 
the diabetic patients with dyspeptic symptoms did not 
show gastroduodenal lesions that could explain the cli-
nical picture, indicating that other factors may be res-
ponsible for the digestive complaints in these patients. 
Results presented here indicate that H. pylori in-
fection is not related to the presence of dyspeptic 
symptoms, confirming recent literature data (8,21). 
The infection was found in 34.4% of the patients, si-
milar to another Brazilian study with DM1 adolescent 
patients (22). However, this prevalence is lower than 
the one reported in a Brazilian population study invol-
ving blood donors, which was 65-70% for individuals 
in the same age group (23). It is also lower than that 
observed in patients with functional dyspepsia in a pre-
vious study carried out by our group, which demons-
trated the presence of the bacterium in 65% of the cases 
(24). Data on the prevalence of H. pylori infection in 
DM1 are contradictory. Some studies show greater pre-
valence than the one found in the controls, and others 
show similar prevalence (8). On the other hand, some 
authors reported lower frequency of infection in those 
patients that had the disease for a longer time, due to 
the repeated use of antibiotics (25). This may be the 
explanation for the relatively low proportion of infec-
tions by H. pylori in the group of diabetic patients in 
the present study: they may have been treated countless 
times with antibiotics during the prolonged course of 
their disease. 
A large number of patients with DM1 presented an-
xiety and/or depression disorders, confirming literature 
results (13,14). Besides, an association between depres-
sion and dyspeptic symptoms in these patients was de-
monstrated. The relationship of gastrointestinal symp-
toms with anxiety and depression was already described 
in groups of DM1 and DM2 patients (15). This associa-
tion was also documented in the follow-up of a mixed 
group of patients with DM1 and DM2 during a period 
of two years. It was observed that the onset of depres-
sion symptoms increased three times the risk of gastroin-
testinal symptoms, no matter the type of diabetes (26). 
The mechanisms responsible for the relationship 
between gastrointestinal symptoms and psychologi-
cal factors have not been elucidated in diabetes, yet. 
One of the mechanisms proposed to explain this asso-
ciation in functional dyspepsia is visceral hypersensiti-
vity, that is, an increased perception of gastrointestinal 
sensations (27,28). It was demonstrated that anxiety 
and depression may influence the central processing of 
visceral stimuli, increasing the perception of gastroin-
testinal sensations (29). Gastrointestinal symptoms, on 
their turn, may increase the levels of anxiety and de-
pression, leading to a vicious cycle. Once the studies 
on diabetes already demonstrated abnormalities in the 
perception of visceral sensations in different parts of the 
gastrointestinal tract (30), it may be inferred that, simi-
lar to what was observed in functional diseases, the rela-
tionship between psychological factors and gastrointes-
tinal symptoms in diabetes may be explained, at least in 
part, by visceral hypersensitivity (15). This hypothesis 
still needs to be confirmed by new studies. 
In spite of the fact that almost all diabetic patients 
in the study presented inadequate glycemic control, the 
levels of HbA1c were significantly higher in dyspeptic 
patients than in those without dyspepsia, suggesting a 
role of glycemic control in the production of dyspep-
tic symptoms in DM1. These results are in agreement 
with the observations of other authors (2,31). Labora-
tory studies in which patients were submitted to gastric 
distention by means of the insufflation of intragastric 
balloons showed that severe hyperglycemia increases 
the perception of nausea and bloating (30-32), sugges-
ting that visceral hypersensitivity may also be involved 
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in the relationship between glycemic control and dys-
peptic symptoms in DM1. New studies are necessary to 
explore this hypothesis. 
According to the data presented here, there was no 
association between digestive symptoms and peripheral 
neuropathy or other diabetes complications. However, 
these results do not enable us to rule out the partici-
pation of autonomic neuropathy in the pathogenesis of 
dyspeptic symptoms, once the appropriate tests to inves-
tigate this change were not used in the present study. It 
is important to mention, however, that previous studies 
did not evidence good correlations between digestive 
symptoms and diabetic autonomic neuropathy, sugges-
ting a multifactorial physiopathology for dyspepsia in 
these patients (5,30). The results of the present study 
seem to fit the current view that digestive symptoms 
in DM1 are result of a complex relationship between 
psychological changes, glycemic control, visceral hyper-
sensitivity, and autonomic neuropathy (15,33).
The evaluation of data on BMI in the studied group 
evidences a high percentage of overweight patients, 
confirming recent studies on DM1 (34,35). However, 
the values for nutritional parameters in dyspeptic pa-
tients were reduced compared with those observed in 
patients without dyspepsia, suggesting that digestive 
symptoms may influence the nutritional status of DM1 
patients. As patients related their digestive complaints 
with the ingestion of different foods, it is possible that 
food intake in these patients was reduced due to the 
severity of the symptoms, leading to the changes in 
nutritional status. This possible relationship should be 
adequately investigated in future studies. 
In conclusion, dyspeptic symptoms may be associa-
ted with worse glycemic control and presence of de-
pression, in most of the patients with DM1. Besides, 
dyspepsia seems to negatively affect the nutritional 
status of the diabetic patients. Therefore, it is impor-
tant that the endocrinologist considers these symptoms 
and recognize that adequate treatment of digestive 
complaints also depends on the effective approach of 
psychosocial factors involved. 
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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